McKesson (NYSE:MCK) Issues FY25 Earnings Guidance

McKesson (NYSE:MCK) updated its FY25 earnings guidance on Wednesday. The company provided EPS guidance of $31.75-32.55 for the period, compared to the consensus EPS estimate of $31.74.

McKesson Stock Up 0.5 %

NYSE:MCK traded up $3.19 on Wednesday, hitting $617.51. The stock had a trading volume of 840,415 shares, compared to its average volume of 705,391. The business’s 50-day simple moving average is $591.09 and its two-hundred day simple moving average is $549.29. The stock has a market cap of $80.24 billion, a price-to-earnings ratio of 27.59, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. McKesson has a 52-week low of $404.72 and a 52-week high of $637.51.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $6.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.34 by ($0.16). McKesson had a negative return on equity of 245.88% and a net margin of 0.97%. The business had revenue of $76.36 billion during the quarter, compared to analysts’ expectations of $79.32 billion. During the same period in the previous year, the business posted $7.19 EPS. The business’s quarterly revenue was up 10.8% compared to the same quarter last year. As a group, equities research analysts anticipate that McKesson will post 31.68 EPS for the current year.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd will be paid a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 0.46%. This is a positive change from McKesson’s previous quarterly dividend of $0.62. The ex-dividend date is Friday, August 30th. McKesson’s dividend payout ratio is 11.08%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on MCK. Citigroup increased their price objective on shares of McKesson from $620.00 to $670.00 and gave the stock a buy rating in a research note on Friday, July 19th. Evercore ISI raised their price target on McKesson from $600.00 to $660.00 and gave the company an outperform rating in a report on Tuesday, July 9th. Robert W. Baird upped their price objective on McKesson from $679.00 to $694.00 and gave the stock an outperform rating in a research note on Tuesday, July 9th. Barclays lifted their target price on McKesson from $571.00 to $596.00 and gave the company an overweight rating in a research note on Wednesday, May 8th. Finally, Argus lifted their target price on McKesson from $570.00 to $670.00 and gave the stock a buy rating in a report on Monday, June 24th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of Moderate Buy and an average target price of $599.33.

Insider Activity at McKesson

In other news, EVP Thomas L. Rodgers sold 789 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $557.40, for a total value of $439,788.60. Following the completion of the sale, the executive vice president now owns 7,909 shares in the company, valued at approximately $4,408,476.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $574.41, for a total value of $2,155,760.73. Following the transaction, the chief executive officer now owns 89,845 shares of the company’s stock, valued at approximately $51,607,866.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Thomas L. Rodgers sold 789 shares of the business’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $557.40, for a total transaction of $439,788.60. Following the completion of the sale, the executive vice president now directly owns 7,909 shares of the company’s stock, valued at $4,408,476.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,320 shares of company stock worth $19,041,332. Company insiders own 0.11% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.